Convergent Ventures, LLC
Convergent Management, Inc.
Convergent Cycling & Performance Products

 
   
 

Convergent Ventures is currently focused on the continued growth and development of the following companies:

 
 
 
Encode Bio is developing a novel compound to treat several inflammatory and autoimmune diseases, including rheumatoid arthritis and inflammatory bowel disease. Encode is managed by its founding CEO, Mr. Nima Shiva, and has close ties to the California Institute of Technology through its scientific advisory board members, Professor Henry Lester and Professor Dennis Dougherty.

Convergent Ventures, LLC was a founding investor in Encode Bio and Mr. Robbins is a Director of the company
SiDMAP, LLC provides metabolic profiling and phenotyping services and biomarker discovery services to pharmaceutical and biotech companies and other research organizations involved in drug R&D and in the study of disease.

Mr. Robbins has served as COO of SiDMAP and Ms. Hawkes has served as Manager, Business Development.
G-Form, LLC makes innovative, impact-protective, and shock-absorbing products for sports and athletics, extreme recreation, tactical applications, and for the protection of personal electronic devices.

Convergent Cycling & Performance Products operates a U.S. national network of independent sales representatives on behalf of G-Form and provides strategic and tactical advice to the company.